TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ACIU

AC Immune Ltd

Healthcare · Biotechnology

2.60$ +3.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

AC Immune Ltd (ACIU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 150 million CHF. Tick rows to compare them in a chart.

All figures in millions of CHF.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACIU
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
143 183 167 238 244 231 211 190 172 154 137 150
86 125 110 181 188 172 152 132 114 97 80 93
32 78 57 52 32 36 20 26 28 27 19 28
80 103 105 175 158 165 146 127 108 92 75 75
0.3 15 0.3 0.4 25 1.1 0.9 0.5 0.4 1.0 0.2 14
-0.4 -0.6 -0.9 – – – – – – – – –
– – – – – – – – – – 50 –
50 50 50 50 50 50 50 50 50 50 – 50
17 22 23 114 114 119 116 115 109 109 106 115
12 14 14 101 101 101 99 99 98 95 92 100
0.6 0.7 0.7 0.7 0.7 1.0 1.0 1.0 1.0 0.9 0.8 0.8
1.5 1.7 2.8 1.4 1.4 2.7 2.4 2.7 1.6 2.1 1.3 1.5
126 161 145 123 130 112 95 75 62 45 32 35
-310 -316 -333 -355 -349 -368 -386 -407 -420 -440 -453 -450
84 84 99 100 101 101 100 101 99 101 99 99

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?